1. Home
  2. MRDB vs ESLA Comparison

MRDB vs ESLA Comparison

Compare MRDB & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRDB
  • ESLA
  • Stock Information
  • Founded
  • MRDB 2010
  • ESLA 2021
  • Country
  • MRDB United States
  • ESLA United States
  • Employees
  • MRDB N/A
  • ESLA N/A
  • Industry
  • MRDB Blank Checks
  • ESLA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MRDB Finance
  • ESLA Health Care
  • Exchange
  • MRDB Nasdaq
  • ESLA Nasdaq
  • Market Cap
  • MRDB 37.5M
  • ESLA 48.4M
  • IPO Year
  • MRDB N/A
  • ESLA N/A
  • Fundamental
  • Price
  • MRDB $0.54
  • ESLA $1.84
  • Analyst Decision
  • MRDB
  • ESLA
  • Analyst Count
  • MRDB 0
  • ESLA 0
  • Target Price
  • MRDB N/A
  • ESLA N/A
  • AVG Volume (30 Days)
  • MRDB 88.0K
  • ESLA 33.1K
  • Earning Date
  • MRDB 08-12-2024
  • ESLA 08-06-2024
  • Dividend Yield
  • MRDB N/A
  • ESLA N/A
  • EPS Growth
  • MRDB N/A
  • ESLA N/A
  • EPS
  • MRDB N/A
  • ESLA N/A
  • Revenue
  • MRDB $54,031,000.00
  • ESLA N/A
  • Revenue This Year
  • MRDB N/A
  • ESLA N/A
  • Revenue Next Year
  • MRDB N/A
  • ESLA N/A
  • P/E Ratio
  • MRDB N/A
  • ESLA N/A
  • Revenue Growth
  • MRDB 11.24
  • ESLA N/A
  • 52 Week Low
  • MRDB $0.16
  • ESLA $0.81
  • 52 Week High
  • MRDB $1.02
  • ESLA $33.00
  • Technical
  • Relative Strength Index (RSI)
  • MRDB 49.07
  • ESLA 73.57
  • Support Level
  • MRDB $0.54
  • ESLA $1.20
  • Resistance Level
  • MRDB $0.55
  • ESLA $1.68
  • Average True Range (ATR)
  • MRDB 0.02
  • ESLA 0.14
  • MACD
  • MRDB -0.00
  • ESLA 0.03
  • Stochastic Oscillator
  • MRDB 27.12
  • ESLA 95.86

About MRDB MariaDB plc

MariaDB PLC is a new generation cloud database company whose products are used by companies, reaching over a billion users through Linux distributions, downloaded over a billion times, and used across all types of use cases and industries. It operates as a single segment within the Software-as-a-Service ("SaaS") space. The company operates in EMEA, APAC and America, out of which it generates maximum revenue from America.

About ESLA Estrella Immunopharma Inc.

Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.

Share on Social Networks: